Literature DB >> 22031372

[Financial challenges to access tuberculosis treatment in Ribeirão Preto - São Paulo].

Ricardo Alexandre Arcêncio1, Tiemi Arakawa, Mayra Fernanda Oliveira, Roxana Isabel Cardozo-Gonzales, Lucia Marina Scatena, Antônio Ruffino-Netto, Tereza Cristina Scatena Villa.   

Abstract

The objective of this study was to analyze the financial challenges that patients have to deal with to access the Tuberculosis (TB) Care Reference Centers in Ribeirão Preto. Adjustments were made to the Primary Care Assessment (PCAT) and an opinion poll was made with one-hundred patients following treatment and 16 health care professionals working at TB Reference Centers in Ribeirão Preto. Anova, Kruskall Wallis and chi-square tests were used. Most patients were males and most health care professionals were female. Differences were found between Centers C and A, in that Center C (p=0.028) offers a bus pass, and in A (p=0.010) patients paid for their own transportation. The indicator medical appointment in 24 hours showed a satisfactory level. There were disagreements between the reports from patients and health professionals as to the center offering the bus pass. Patients face challenges in their treatment, such as costs with transportation or being late for work, which result in losses in the family income.

Entities:  

Mesh:

Year:  2011        PMID: 22031372     DOI: 10.1590/s0080-62342011000500013

Source DB:  PubMed          Journal:  Rev Esc Enferm USP        ISSN: 0080-6234            Impact factor:   1.086


  1 in total

1.  Patients' perception regarding the influence of individual and social vulnerabilities on the adherence to tuberculosis treatment: a qualitative study.

Authors:  Rosiane Davina da Silva; Fernanda Darliane Tavares de Luna; Aguinaldo José de Araújo; Edwirde Luiz Silva Camêlo; Maria Rita Bertolozzi; Paula Hino; Sheylla Nadjane Batista Lacerda; Sayonara Maria Lia Fook; Tânia Maria Ribeiro Monteiro de Figueiredo
Journal:  BMC Public Health       Date:  2017-09-19       Impact factor: 3.295

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.